FDA Approves First Oral PCSK9 Cholesterol Drug Lipfendra
7d
Breaking
3
The Food and Drug Administration approved a first oral PCSK9-class cholesterol pill on Friday, July 17, 2026, creating a new non-statin option that could help millions lower LDL cholesterol. CBS News